453 related articles for article (PubMed ID: 16127064)
1. Effects of intratracheal administration of novispirin G10 on a rat model of mucoid Pseudomonas aeruginosa lung infection.
Song Z; Wu H; Mygind P; Raventos D; Sonksen C; Kristensen HH; Høiby N
Antimicrob Agents Chemother; 2005 Sep; 49(9):3868-74. PubMed ID: 16127064
[TBL] [Abstract][Full Text] [Related]
2. Effects of Chinese medicinal herbs on a rat model of chronic Pseudomonas aeruginosa lung infection.
Song Z; Johansen HK; Moser C; Høiby N
APMIS; 1996 May; 104(5):350-4. PubMed ID: 8703440
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
4. Augmented effect of early antibiotic treatment in mice with experimental lung infections due to sequentially adapted mucoid strains of Pseudomonas aeruginosa.
van Gennip M; Moser C; Christensen LD; Bjarnsholt T; Calum H; Jensen PØ; Christophersen L; Hougen HP; Ciofu O; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2009 Dec; 64(6):1241-50. PubMed ID: 19815632
[TBL] [Abstract][Full Text] [Related]
5. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia.
Song ZJ; Johansen HK; Faber V; Høiby N
APMIS; 1997 Jun; 105(6):438-44. PubMed ID: 9236860
[TBL] [Abstract][Full Text] [Related]
6. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
7. Cytokine modulating effect of ginseng treatment in a mouse model of Pseudomonas aeruginosa lung infection.
Song Z; Moser C; Wu H; Faber V; Kharazmi A; Høiby N
J Cyst Fibros; 2003 Sep; 2(3):112-9. PubMed ID: 15463859
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial peptide therapeutics for cystic fibrosis.
Zhang L; Parente J; Harris SM; Woods DE; Hancock RE; Falla TJ
Antimicrob Agents Chemother; 2005 Jul; 49(7):2921-7. PubMed ID: 15980369
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial activity of the recombinant designer host defence peptide P-novispirin G10 in infected full-thickness wounds of porcine skin.
Jacobsen F; Mohammadi-Tabrisi A; Hirsch T; Mittler D; Mygind PH; Sonksen CP; Raventos D; Kristensen HH; Gatermann S; Lehnhardt M; Daigeler A; Steinau HU; Steinstraesser L
J Antimicrob Chemother; 2007 Mar; 59(3):493-8. PubMed ID: 17289767
[TBL] [Abstract][Full Text] [Related]
10. Synthetic furanones inhibit quorum-sensing and enhance bacterial clearance in Pseudomonas aeruginosa lung infection in mice.
Wu H; Song Z; Hentzer M; Andersen JB; Molin S; Givskov M; Høiby N
J Antimicrob Chemother; 2004 Jun; 53(6):1054-61. PubMed ID: 15117922
[TBL] [Abstract][Full Text] [Related]
11. In vivo efficacy and pharmacokinetics of tomopenem (CS-023), a novel carbapenem, against Pseudomonas aeruginosa in a murine chronic respiratory tract infection model.
Morinaga Y; Yanagihara K; Nakamura S; Yamamoto K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Yamada Y; Kohno S; Kamihira S
J Antimicrob Chemother; 2008 Dec; 62(6):1326-31. PubMed ID: 18835805
[TBL] [Abstract][Full Text] [Related]
12. Vaccination promotes TH1-like inflammation and survival in chronic Pseudomonas aeruginosa pneumonia. A new prophylactic principle.
Johansen HK; Cryz SJ; Hougen HP; Moser C; Høiby N
Behring Inst Mitt; 1997 Feb; (98):269-73. PubMed ID: 9382750
[TBL] [Abstract][Full Text] [Related]
13. Chronic Pseudomonas aeruginosa lung infection in normal and athymic rats.
Johansen HK; Espersen F; Pedersen SS; Hougen HP; Rygaard J; Høiby N
APMIS; 1993 Mar; 101(3):207-25. PubMed ID: 8507458
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa alginate is refractory to Th1 immune response and impedes host immune clearance in a mouse model of acute lung infection.
Song Z; Wu H; Ciofu O; Kong KF; Høiby N; Rygaard J; Kharazmi A; Mathee K
J Med Microbiol; 2003 Sep; 52(Pt 9):731-740. PubMed ID: 12909647
[TBL] [Abstract][Full Text] [Related]
15. [The establishment of a rat model of chronic pulmonary infection due to Pseudomonas aeruginosa].
Wang WF; Fang XQ; Liu YN
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):46-50. PubMed ID: 18346380
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
17. Co-administration of aqueous ginseng extract with tobramycin stimulates the pro-inflammatory response and promotes the killing of Pseudomonas aeruginosa in the lungs of infected rats.
Alipour M; Omri A; Lui EM; Suntres ZE
Can J Physiol Pharmacol; 2013 Nov; 91(11):935-40. PubMed ID: 24117261
[TBL] [Abstract][Full Text] [Related]
18. Activity of novispirin G10 against Pseudomonas aeruginosa in vitro and in infected burns.
Steinstraesser L; Tack BF; Waring AJ; Hong T; Boo LM; Fan MH; Remick DI; Su GL; Lehrer RI; Wang SC
Antimicrob Agents Chemother; 2002 Jun; 46(6):1837-44. PubMed ID: 12019098
[TBL] [Abstract][Full Text] [Related]
19. Expression and antimicrobial function of bactericidal permeability-increasing protein in cystic fibrosis patients.
Aichele D; Schnare M; Saake M; Röllinghoff M; Gessner A
Infect Immun; 2006 Aug; 74(8):4708-14. PubMed ID: 16861658
[TBL] [Abstract][Full Text] [Related]
20. Early rise of anti-pseudomonas antibodies and a mucoid phenotype of pseudomonas aeruginosa are risk factors for development of chronic lung infection--a case control study.
Pressler T; Frederiksen B; Skov M; Garred P; Koch C; Høiby N
J Cyst Fibros; 2006 Jan; 5(1):9-15. PubMed ID: 16412706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
